Biotech Values

[jessellivermore]

Re Amrn...

First off since I am too lazy to find Dew's post where he suggests Abbott could be a player in the Amarin sweeps, this should add a some creditability.

http://www.medpagetoday.com/Cardiology/Dyslipidemia/26133

Good figuring ":>) Dew...This should put Abbott right in the middle of it and get the buyout (if there is one) way up there. The mention of $20PPS IMHO is ridiculous..This company (except for long long term) is as close to CocaCola as a biotech can get...If they sell this for less than 60$ they are stupid...

The source for the Lazard connection was a Dublin Times article. I posted on the Yahoo board that the article sounded like pure bs turned in by a reporter needing to file..

Respectfully ":>) JL